eMedicine Specialties > Radiology > Gastrointestinal

Cholecystitis, Acalculous: Imaging

Author: J David Lane, MD, RT, Chief, CMH Vascular and Interventional Radiology, Wisconsin Radiology Specialists, SC; Former Section Chief, Assistant Professor, Vascular and Interventional Radiology, Walter Reed Army Medical Center, Uniformed Services University of the Health Sciences
Coauthor(s): Nick Lomis, MD, QI Coordinator, Diagnostic Radiology Service, Assistant Chief, Interventional Radiology, Diagnostic Radiology, Interventional Radiology Section, Walter Reed Army Medical Center
Contributor Information and Disclosures

Updated: Oct 16, 2008

Radiography

Findings

Plain film radiography is of limited use in the diagnosis of acute acalculous cholecystitis. Emphysematous cholecystitis may occur as a complication of acute cholecystitis; more than one half of such cases occur in the setting of acalculous disease. This form of complicated cholecystitis typically is seen in older male patients with diabetes. On upright abdominal radiographs, acute acalculous cholecystitis (AAC) may be evinced by the presence of an air-fluid level in the right upper quadrant; such a finding represents gas in the gallbladder lumen. The presence of intramural gas is indicated by findings of a curvilinear gas collection that conforms to the gallbladder wall. Gas is visualized only in more severe cases on plain film. US and CT are much more useful. The presence of gas is often associated with gangrene and perforation (see Images 1, 9, 14).

Computed Tomography

Findings

CT often is performed as the diagnostic examination of choice in patients presenting with abdominal pain in the critical care setting or in patients with fever or leukocytosis of undefined etiology. CT offers the advantage of evaluating the entire chest and abdomen; it has the disadvantage of requiring transport to the scanner. One should be familiar with the CT signs that suggest acalculous cholecystitis in the appropriate clinical setting (see Images 2, 3, 10).

The diagnosis of acute acalculous cholecystitis (AAC) with CT requires that 2 major diagnostic criteria be met or, alternatively, that 1 major criterion and 2 minor criteria be met. These criteria are as follows:

  • Major criteria
    • Gallbladder wall thickening greater than 3 mm
    • Subserosal halo (ie, gallbladder wall edema)
    • Pericholecystic fatty inflammation
    • Pericholecystic fluid (without ascites or hypoalbuminemia)
    • Mucosal sloughing
    • Intramural gas
  • Minor criteria
    • Gallbladder distention (>5 cm transverse)
    • High-attenuation bile (sludge)

The normal gallbladder wall is barely perceptible as a thin enhancing rim on contrast-enhanced CT. In the absence of gallstones, imaging relies on ancillary findings of cholecystitis.

CT findings for patients with AAC are as follows:

  • Gallbladder wall thickening
  • Mucosal irregularity
  • Luminal distention
  • Increased bile density (biliary sludge)
  • Intramural or intraluminal gas
  • Intraluminal hemorrhage
  • Localized pericholecystic fluid collections
  • Inflammatory infiltration of pericholecystic fat
  • Indistinctness of the liver-gallbladder interface

Degree of Confidence

Although mucosal sloughing and intramural gas are specific findings, they are observed infrequently. Isolated local pericholecystic fluid collections and pericholecystic inflammatory changes are relatively specific and suggest advanced disease, but they lose specificity in the setting of ascites, recent abdominal surgery, or anasarca.

Reported sensitivity and specificity vary but generally have been greater than 90-95%. As with other imaging modalities, the specificity of many of these findings is decreased in the typical populations at risk for acalculous cholecystitis because of comorbid conditions, such as recent surgery or trauma, multisystemic organ failure, ascites, or hypoalbuminemia.

Ultrasonography

Findings

Usually, sonography is the first examination performed in cases of possible acalculous cholecystitis. US has the advantages of being readily available, portable to the bedside, and able to identify other adjacent pathologies. Primary disadvantages of US include the high incidence of nonspecific abnormal examinations and the inability to survey the entire abdomen (see Images 6-8, 11-12).8,9,10

The normal gallbladder has sonolucent bile and a thin wall; no localized pain is present. Sonographic signs compatible with acalculous cholecystitis include the following:

  • Gallbladder wall thickening
  • Sonographically localized tenderness over the gallbladder
  • Subserosal edema
  • Pericholecystic fluid
  • Gallbladder distension
  • Biliary sludge
  • The presence of gas

Failure of the gallbladder to contract after the infusion of cholecystokinin has been reported as an additional criterion, but the response often is too variable to be of use in these patients.

The diagnosis of acute acalculous cholecystitis (AAC) with US requires that 2 major diagnostic criteria be met or, alternatively, that 1 major criterion and 2 minor criteria be met. These criteria are as follows:

  • Major criteria
    • Gallbladder wall thickening greater than 3 mm
    • Striated gallbladder (ie, gallbladder wall edema)
    • Sonographic Murphy sign (ie, localized gallbladder tenderness)
    • Pericholecystic fluid (without ascites or hypoalbuminemia)
    • Mucosal sloughing
    • Intramural gas
  • Minor criteria
    • Gallbladder distention (>5 cm transverse)
    • Echogenic bile (sludge)

Gallbladder wall thickness should be measured in the transverse plane, provided the gallbladder has not collapsed. The presence of ascites or decreased oncotic pressure (as occurs in patients with hypoalbuminemia) confuses the finding, unless the finding is markedly discordant. Similarly, the presence of pericholecystic fluid is not meaningful in the presence of generalized ascites; however, the occurrence of pericholecystic fluid as a localized finding often signifies advanced disease or perforation. The sonographic Murphy sign is the most specific sonographic finding, but often it cannot be evaluated because of the patient's clinical condition.

Following diagnostic needle aspiration of the gallbladder, results of bile Gram stain and culture are often normal; the sensitivity is less than 50%, and the results of culture are delayed. Therefore, the test is of limited value for the diagnosis of AAC. Culture is performed routinely at the time of therapeutic cholecystostomy and may guide antibiotic selection.

Degree of Confidence

The reported sensitivity and specificity of sonography in the evaluation of acalculous cholecystitis vary from 23-95% and 40-95%, respectively; this degree of variance occurs because of differences in patient populations, clinical courses, and imaging technologies employed over time. The sensitivity and specificity are greater than 90% in the subset of patients with acalculous cholecystitis who present in the outpatient setting.

Overall, the sensitivity and specificity approach 70%. As the proportion of patients in the critical care environment increases, the diagnostic accuracy decreases. Several studies have documented a high incidence of abnormal gallbladder sonograms in the ICU environment in asymptomatic patients who were not suspected of having acalculous cholecystitis.

At least 1 abnormal finding was seen in 50-85% of patients in this setting; 3 abnormal findings were seen in as many as 57% of patients. None of these patients had localized gallbladder tenderness by sonography. Serial sonography has been of benefit in some studies; the fact that the appearance on short-term follow-up images progressively worsens increases the specificity for diagnosis.

Nuclear Imaging

Findings

Hepatobiliary scintigraphy (HBS) is a physiologic test that evaluates hepatic bile formation, excretion, and ductal functional patency.

Imaging typically is performed with dynamic image acquisition for up to 4 hours following the intravenous (IV) administration of 5 mCi of a technetium-99m-labeled iminodiacetic acid derivative. Peak liver uptake is at 5-10 minutes, with subsequent gallbladder visualization by 20 minutes and duodenal visualization by 30 minutes (see Images 4-5).

If nonvisualization or questionable visualization of the gallbladder occurs but adequate hepatic uptake and excretion into the bowel are seen, IV morphine sulfate (0.04 mg/kg) may be administered at 30-40 minutes, with imaging carried out for up to 1 hour. This raises intrabiliary pressure by inducing contraction of the sphincter of Oddi and filling of the gallbladder, provided the cystic duct remains patent. A lateral view may be helpful if a question remains concerning gallbladder filling; the gallbladder is located anteriorly in this projection.

Some have attempted to improve accuracy by pretreating the patient with cholecystokinin infusion before performing HBS, so as to empty the distended gallbladder. HBS may be nondiagnostic in patients with liver failure and intrahepatic cholestasis of any cause because of the inability to conjugate and excrete the radiotracer.

Additional useful findings on cholescintigraphy include the presence of an area of increased pericholecystic radiotracer accumulation in the gallbladder fossa. This rim sign is associated with complications such as gangrene. Radiotracer extravasation rarely may be visualized in the setting of perforated gangrenous cholecystitis if the cystic duct remains patent.

Degree of Confidence

Hepatobiliary scintigraphy (HBS) is accurate in the diagnosis of calculous cholecystitis because the primary event is believed to be cystic duct obstruction. In cases of acalculous cholecystitis, functional obstruction usually occurs in the disease process but is variable and is not the primary process. Not surprisingly, the sensitivity and specificity of HBS are decreased in this setting.

In general, diagnostic quality studies with augmentation yield a sensitivity of 80-90% and a specificity of 90-100%.

False Positives/Negatives

The false-positive rate without pharmacologic augmentation is as high as 40% in some series, decreasing the specificity of the test. With morphine augmentation, the false-positive rate is decreased and the specificity is improved.

False-negative results (gallbladder filling in presence of acalculous cholecystitis) also may occur. Early filling of the gallbladder (within the first 30 min) excludes the diagnosis of acalculous cholecystitis, but with delayed filling after augmentation, the false-negative rate may be as high as 20%.

Angiography

Findings

No role exists for angiography in the diagnosis of acalculous cholecystitis.

More on Cholecystitis, Acalculous

Overview: Cholecystitis, Acalculous
Imaging: Cholecystitis, Acalculous
Follow-up: Cholecystitis, Acalculous
Multimedia: Cholecystitis, Acalculous
References

References

  1. Kalliafas S, Ziegler DW, Flancbaum L, Choban PS. Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome. Am Surg. May 1998;64(5):471-5. [Medline].

  2. Shridhar Ganpathi I, Diddapur RK, Eugene H, Karim M. Acute acalculous cholecystitis: challenging the myths. HPB (Oxford). 2007;9(2):131-4. [Medline].

  3. Katsinelos P, Pilpilidis I, Papaziogas B, Chatzimavroudis G, Paroutoglou G, Mimidis K, et al. Fatal acute acalculous cholecystitis as an early complication after radiation therapy.. Chirurgia (Bucur). Mar-Apr 2008;103(2):223-6. [Medline].

  4. Iaria C, Arena L, Di Maio G, Fracassi MG, Leonardi MS, Famulari C, et al. Acute acalculous cholecystitis during the course of primary Epstein-Barr virus infection: a new case and a review of the literature. Int J Infect Dis. Jul 2008;12(4):391-5. [Medline].

  5. Yombi JC, Meuris CM, Van Gompel AM, Ben Younes M, Vandercam BC. Acalculous cholecystitis in a patient with Plasmodium falciparum infection: a case report and literature review. J Travel Med. May-Jun 2006;13(3):178-80. [Medline].

  6. D''Agostino HB, vanSonnenberg E, Sanchez RB, et al. Imaging of the percutaneous cholecystostomy tract: observations and utility. Radiology. Dec 1991;181(3):675-8. [Medline].

  7. Flancbaum L, Choban PS. Use of morphine cholescintigraphy in the diagnosis of acute cholecystitis in critically ill patients. Intensive Care Med. Feb 1995;21(2):120-4. [Medline].

  8. Boland GW, Slater G, Lu DS, et al. Prevalence and significance of gallbladder abnormalities seen on sonography in intensive care unit patients. AJR Am J Roentgenol. Apr 2000;174(4):973-7. [Medline].

  9. Helbich TH, Mallek R, Madl C, et al. Sonomorphology of the gallbladder in critically ill patients. Value of a scoring system and follow-up examinations. Acta Radiol. Jan 1997;38(1):129-34. [Medline].

  10. Molenat F, Boussuges A, Valantin V, Sainty JM. Gallbladder abnormalities in medical ICU patients: an ultrasonographic study. Intensive Care Med. Apr 1996;22(4):356-8. [Medline].

  11. Boland GW, Lee MJ, Leung J, Mueller PR. Percutaneous cholecystostomy in critically ill patients: early response and final outcome in 82 patients. AJR Am J Roentgenol. Aug 1994;163(2):339-42. [Medline].

  12. Byrne MF, Suhocki P, Mitchell RM, et al. Percutaneous cholecystostomy in patients with acute cholecystitis: experience of 45 patients at a US referral center. J Am Coll Surg. Aug 2003;197(2):206-11. [Medline].

  13. Conway JD, Russo MW, Shrestha R. Endoscopic stent insertion into the gallbladder for symptomatic gallbladder disease in patients with end-stage liver disease. Gastrointest Endosc. Jan 2005;61(1):32-6. [Medline].

  14. England RE, McDermott VG, Smith TP, et al. Percutaneous cholecystostomy: who responds?. AJR Am J Roentgenol. May 1997;168(5):1247-51. [Medline].

  15. Johlin FC, Neil GA. Drainage of the gallbladder in patients with acute acalculous cholecystitis by transpapillary endoscopic cholecystotomy. Gastrointest Endosc. Sep-Oct 1993;39(5):645-51. [Medline].

  16. Nemcek AA Jr, Bernstein JE, Vogelzang RL. Percutaneous cholecystostomy: does transhepatic puncture preclude a transperitoneal catheter route?. J Vasc Interv Radiol. Nov 1991;2(4):543-7. [Medline].

  17. Patel M, Miedema BW, James MA, Marshall JB. Percutaneous cholecystostomy is an effective treatment for high-risk patients with acute cholecystitis. Am Surg. Jan 2000;66(1):33-7. [Medline].

  18. Tazawa J, Sanada K, Maekawa S, et al. Gallbladder aspiration for acute cholecystitis in high-surgical-risk patients. J Gastroenterol Hepatol. Apr 2003;18(4):463-5. [Medline].

  19. vanSonnenberg E, D''Agostino HB, Goodacre BW, et al. Percutaneous gallbladder puncture and cholecystostomy: results, complications, and caveats for safety. Radiology. Apr 1992;183(1):167-70. [Medline].

  20. Ginat D, Saad WE. Cholecystostomy and transcholecystic biliary access. Tech Vasc Interv Radiol. Mar 2008;11(1):2-13. [Medline].

  21. Griniatsos J, Petrou A, Pappas P, Revenas K, Karavokyros I, Michail OP, et al. Percutaneous cholecystostomy without interval cholecystectomy as definitive treatment of acute cholecystitis in elderly and critically ill patients. South Med J. Jun 2008;101(6):586-90. [Medline].

  22. Chopra S, Dodd GD 3rd, Mumbower AL, et al. Treatment of acute cholecystitis in non-critically ill patients at high surgical risk: comparison of clinical outcomes after gallbladder aspiration and after percutaneous cholecystostomy. AJR Am J Roentgenol. Apr 2001;176(4):1025-31. [Medline].

  23. Cullen JJ, Maes EB, Aggrawal S, et al. Effect of endotoxin on opossum gallbladder motility: a model of acalculous cholecystitis. Ann Surg. Aug 2000;232(2):202-7. [Medline].

  24. Prevot N, Mariat G, Mahul P, et al. Contribution of cholescintigraphy to the early diagnosis of acute acalculous cholecystitis in intensive-care-unit patients. Eur J Nucl Med. Oct 1999;26(10):1317-25. [Medline].

  25. Tsakayannis DE, Kozakewich HP, Lillehei CW. Acalculous cholecystitis in children. J Pediatr Surg. Jan 1996;31(1):127-30; discussion 130-1. [Medline].

Further Reading

Keywords

acalculous cholecystitis, gallbladder inflammation, acalculous gallbladder inflammation, cholecystitis, gallbladder disease, biliary tract disease, digestive system disease, necrotizing cholecystitis, acute acalculous cholecystitis

Contributor Information and Disclosures

Author

J David Lane, MD, RT, Chief, CMH Vascular and Interventional Radiology, Wisconsin Radiology Specialists, SC; Former Section Chief, Assistant Professor, Vascular and Interventional Radiology, Walter Reed Army Medical Center, Uniformed Services University of the Health Sciences
J David Lane, MD, RT is a member of the following medical societies: Alpha Omega Alpha, American College of Radiology, American Heart Association, American Medical Association, American Roentgen Ray Society, Radiological Society of North America, and Society of Interventional Radiology
Disclosure: Nothing to disclose.

Coauthor(s)

Nick Lomis, MD, QI Coordinator, Diagnostic Radiology Service, Assistant Chief, Interventional Radiology, Diagnostic Radiology, Interventional Radiology Section, Walter Reed Army Medical Center
Nick Lomis, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, and Radiological Society of North America
Disclosure: Nothing to disclose.

Medical Editor

Zahir Amin, MD, MBBS, MRCP, FRCR, Consulting Staff, Department of Imaging, University College Hospital, UK
Zahir Amin, MD, MBBS, MRCP, FRCR is a member of the following medical societies: British Institute of Radiology, British Medical Association, and Royal College of Radiologists
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

Spencer B Gay, MD, Professor of Radiology, Director of Body Computed Tomography, Department of Radiology, University of Virginia Health Sciences Center
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

John Karani, MBBS, FRCR, Consulting Staff, Department of Radiology, King's College Hospital, London
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.